Genetic Variants in HMGCR Linked to Increased Cataract Risk

WEDNESDAY, June 15, 2022 -- Genetically proxied inhibition of the 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) gene, which mimics statin treatment, is associated with increased risk of cataract, according to a study published online June...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news